KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $133.39 $156.84 Friday, 26th Apr 2024 ASND stock ended at $135.90. This is 0.752% less than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 4.81% from a day low at $133.39 to a day high of $139.81.
90 days $128.67 $161.00
52 weeks $66.03 $161.00

Historical Ascendis Pharma A/S prices

Date Open High Low Close Volume
Mar 22, 2023 $109.33 $109.75 $105.41 $105.55 116 410
Mar 21, 2023 $110.12 $111.23 $106.92 $108.92 176 892
Mar 20, 2023 $108.20 $110.54 $107.18 $109.80 212 193
Mar 17, 2023 $109.08 $109.67 $107.55 $108.14 154 321
Mar 16, 2023 $108.01 $110.44 $105.69 $109.69 167 852
Mar 15, 2023 $107.76 $108.64 $105.76 $108.52 191 403
Mar 14, 2023 $108.88 $110.70 $107.75 $109.36 180 298
Mar 13, 2023 $105.92 $109.03 $104.85 $107.65 219 823
Mar 10, 2023 $108.59 $109.16 $103.85 $106.21 404 758
Mar 09, 2023 $110.09 $111.20 $107.03 $108.79 267 620
Mar 08, 2023 $112.36 $112.87 $107.45 $110.00 330 896
Mar 07, 2023 $113.71 $114.89 $111.14 $112.25 188 103
Mar 06, 2023 $114.12 $114.36 $111.55 $113.56 333 391
Mar 03, 2023 $113.13 $116.10 $112.10 $114.12 233 334
Mar 02, 2023 $112.62 $114.53 $111.23 $113.35 263 394
Mar 01, 2023 $110.79 $114.50 $110.79 $113.21 219 158
Feb 28, 2023 $111.63 $113.39 $110.89 $111.09 231 793
Feb 27, 2023 $114.21 $114.42 $110.57 $111.72 161 866
Feb 24, 2023 $114.40 $115.04 $111.62 $113.39 234 067
Feb 23, 2023 $113.90 $117.40 $113.26 $114.91 272 124
Feb 22, 2023 $112.19 $115.19 $111.40 $114.35 251 793
Feb 21, 2023 $113.63 $117.12 $111.59 $112.32 228 121
Feb 17, 2023 $111.28 $120.11 $108.55 $116.65 566 277
Feb 16, 2023 $110.05 $111.91 $109.03 $111.36 348 383
Feb 15, 2023 $110.75 $116.46 $109.02 $112.00 330 729
Click to get the best stock tips daily for free!

About Ascendis Pharma A/S

Ascendis Pharma A/S Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops Tra... ASND Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT